Trial Profile
Retrospective study of ipilimumab in patients previously treated for stage III or IV malignant melanoma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 02 Dec 2015 New trial record